Report Quota Issues

Pharmacy F-code/ODS code *

Name of the branded drug you had difficulty in obtaining (where appropriate, please specify brand name, strength and formulation) *

Who is your first line wholesaler? Who is your first line wholesaler?

If you did not manage to order the drug from your first line wholesaler, what was their reason for not accepting your order? If you did not manage to order the drug from your first line wholesaler, what was their reason for not accepting your order?

Which other wholesaler(s) did you attempt to order the drug from? * Which other wholesaler(s) did you attempt to order the drug from?

Multiple wholesalers can be selected

If the other wholesaler(s) was unable to supply, what was their reason for not accepting your order? If the other wholesaler(s) was unable to supply, what was their reason for not accepting your order?

If wholesalers were unable to supply, was the drug manufacturer contacted directly for an emergency supply?

Yes

No

If manufacturer was unable to supply, what was their reason for not accepting your order?

Would you like to provide supporting information to allow further investigation into your reported quota issue?

Yes

No

Additional information

As evidence to support further investigation into individual or wider supply issues created by any manufacturer or wholesaler-led drug quota restrictions in place, PSNC may share the information you have provided with any of the following organisations: the Department of Health and Social Care (DHSC), Healthcare Distribution Association (HDA), Association of the British Pharmaceutical Industry (ABPI), relevant wholesaler(s) and manufacturer(s). PSNC encourages contractors to consent to sharing of reports with these organisations to allow them to identify and investigate any regional supply issues and assist with any individual quota issues reported.

I agree to my information being shared

I do not agree to my information being shared

Was prescription validation offered to assist with obtaining stock or lifting a quota allocation?

Yes

No

If so, was proof of prescription provided?

Yes

No

Were you able to obtain stock?

Yes

No

If you answered 'Yes' to above, please select where you managed to source stock from If you answered 'Yes' to above, please select where you managed to source stock from

Was there any impact of the supply issue on the patient?

Approximate time spent sourcing drug affected by quota restrictions? (this may include time spent on email correspondence and phone-calls with suppliers, prescription-validation processes, placing orders and keeping patient(s) updated) Approximate time spent sourcing drug affected by quota restrictions? (this may include time spent on email correspondence and phone-calls with suppliers, prescription-validation processes, placing orders and keeping patient(s) updated)

Do you own an MHRA wholesale dealer licence (wholesale distribution authorisation)?

Yes

No

Please provide a secure email address for further correspondence. The report may be shared with any of the above named organisations, where appropriate, to assist with further investigation into your reported quota issue(s).

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
is-pharmacy	30 days	Hides the 'Do you work in community pharmacy?' hero prompt if the user has already selected 'yes'

Additional information

Latest Dispensing & Supply news

December 2024 Price Concessions 3rd Update

Medicine Supply Notification: Estradiol (Estradot® ) 50micrograms/24 hours, 75micrograms/24 hours, and 100micrograms/24 hours transdermal patches

Three new SSPs issued for Estradot® patches

Medicine Supply Notification: Prednisolone 20mg/100ml rectal solution

Medicine Supply Notification: Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release)

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV)

National Patient Safety Alert: Shortage of Pancreatic enzyme replacement therapy (PERT) – Additional actions

December 2024 Price Concessions 2nd Update

December 2024 Price Concessions: 1st Update

Medicine Supply Notification: Cefalexin 125mg/5ml and 250mg/5ml oral suspensions, sugar free

Medicine Supply Notification: Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges

MHRA Drug Safety Update: December 2024